About Enhancer
| Enhancer ID: | E_01_0814 |
| Species: | human |
| Position : | chr2:15938207-15940207   |
| Biosample name: | |
| Experiment class : | High+Lowthroughput |
| Enhancer type: | Enhancer |
| Disease: | Neuroblastoma |
| Pubmed ID: | 35121888 |
| Enhancer experiment: | Identification of SEs and CRCs,ACE-seq,HiChIP experiments,ATAC-seq |
| Enhancer experiment description: | Three of these subtypes recapitulated known clinical groups; namely, MYCN-amplified, MYCN non-amplified high-risk and MYCN non-amplified low-risk NBs. |
About Target gene
| Target gene : | -- |
| Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
| Less strong evidence: | RNA-Seq |
| Target gene experiment description: | Three of these subtypes recapitulated known clinical groups; namely, MYCN-amplified, MYCN non-amplified high-risk and MYCN non-amplified low-risk NBs. |
About TF
| TF name : | MYCN(MODED,N-myc,NMYC,ODED,bHLHe37) |
| TF experiment: | Identification of SEs and CRCs,ACE-seq,HiChIP experiments,ATAC-seq |
| TF experiment description: | Three of these subtypes recapitulated known clinical groups; namely, MYCN-amplified, MYCN non-amplified high-risk and MYCN non-amplified low-risk NBs. |
About Function
| Enhancer function : | Three of these subtypes recapitulated known clinical groups; namely, MYCN-amplified, MYCN non-amplified high-risk and MYCN non-amplified low-risk NBs. |
| Enhancer function experiment: | Immunohistochemical staining |
| Enhancer function experiment description: |
Three of these subtypes recapitulated known clinical groups; namely, MYCN-amplified, MYCN non-amplified high-risk and MYCN non-amplified low-risk NBs. |
About SNP
| SNP ID: | -- |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| MYCN | Hs_Pathways_Affected_in_Adenoid_Cystic_Carcinoma_WP3651_89271 | wikipathways | 27 |
Enhancer associated network
The number on yellow line represents the distance between enhancer and
target gene